Prevalence of depression and its association with quality of life in clinically stable patients with COVID-19.
J Affect Disord
; 275: 145-148, 2020 10 01.
Article
in English
| MEDLINE | ID: covidwho-627108
ABSTRACT
INTRODUCTION:
High risk of mental health problems is associated with Coronavirus Disease 2019 (COVID-19). This study explored the prevalence of depressive symptoms (depression hereafter) and its relationship with quality of life (QOL) in clinically stable patients with COVID-19.METHODS:
This was an online survey conducted in COVID-19 patients across five designated isolation hospitals for COVID-19 in Hubei province, China. Depression and QOL were assessed with standardized instruments.RESULTS:
A total of 770 participants were included. The prevalence of depression was 43.1% (95%CI 39.6%-46.6%). Binary logistic regression analysis found that having a family member infected with COVID-19 (OR=1.51, Pâ¯=â¯0.01), suffering from severe COVID-19 infection (OR=1.67, Pâ¯=â¯0.03), male gender (OR=0.53, P<0.01), and frequent social media use to obtain COVID-19 related information (OR=0.65, P<0.01) were independently associated with depression. Patients with depression had lower QOL than those without.CONCLUSION:
Depression is highly prevalent in clinically stable patients with COVID-19. Regular screening and appropriate treatment of depression are urgently warranted for this population.Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Quality of Life
/
Coronavirus Infections
Type of study:
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Country/Region as subject:
Asia
Language:
English
Journal:
J Affect Disord
Year:
2020
Document Type:
Article
Affiliation country:
J.jad.2020.06.033
Similar
MEDLINE
...
LILACS
LIS